These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 16118015)
81. Transferrin adsorption onto PLGA nanoparticles governs their interaction with biological systems from blood circulation to brain cancer cells. Chang J; Paillard A; Passirani C; Morille M; Benoit JP; Betbeder D; Garcion E Pharm Res; 2012 Jun; 29(6):1495-505. PubMed ID: 22167349 [TBL] [Abstract][Full Text] [Related]
82. Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Singh N; Jenkins GJ; Asadi R; Doak SH Nano Rev; 2010; 1():. PubMed ID: 22110864 [TBL] [Abstract][Full Text] [Related]
83. Biological properties of iron oxide nanoparticles for cellular and molecular magnetic resonance imaging. Schlorf T; Meincke M; Kossel E; Glüer CC; Jansen O; Mentlein R Int J Mol Sci; 2010 Dec; 12(1):12-23. PubMed ID: 21339973 [TBL] [Abstract][Full Text] [Related]
84. Problems and challenges in the development and validation of human cell-based assays to determine nanoparticle-induced immunomodulatory effects. Oostingh GJ; Casals E; Italiani P; Colognato R; Stritzinger R; Ponti J; Pfaller T; Kohl Y; Ooms D; Favilli F; Leppens H; Lucchesi D; Rossi F; Nelissen I; Thielecke H; Puntes VF; Duschl A; Boraschi D Part Fibre Toxicol; 2011 Feb; 8(1):8. PubMed ID: 21306632 [TBL] [Abstract][Full Text] [Related]
85. Analytical strategies for detecting nanoparticle-protein interactions. Li L; Mu Q; Zhang B; Yan B Analyst; 2010 Jul; 135(7):1519-30. PubMed ID: 20502814 [TBL] [Abstract][Full Text] [Related]
86. Chitosan/TPP and chitosan/TPP-hyaluronic acid nanoparticles: systematic optimisation of the preparative process and preliminary biological evaluation. Nasti A; Zaki NM; de Leonardis P; Ungphaiboon S; Sansongsak P; Rimoli MG; Tirelli N Pharm Res; 2009 Aug; 26(8):1918-30. PubMed ID: 19507009 [TBL] [Abstract][Full Text] [Related]
87. Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearance. Simberg D; Park JH; Karmali PP; Zhang WM; Merkulov S; McCrae K; Bhatia SN; Sailor M; Ruoslahti E Biomaterials; 2009 Aug; 30(23-24):3926-33. PubMed ID: 19394687 [TBL] [Abstract][Full Text] [Related]
88. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Aggarwal P; Hall JB; McLeland CB; Dobrovolskaia MA; McNeil SE Adv Drug Deliv Rev; 2009 Jun; 61(6):428-37. PubMed ID: 19376175 [TBL] [Abstract][Full Text] [Related]
89. Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases. Smola M; Vandamme T; Sokolowski A Int J Nanomedicine; 2008; 3(1):1-19. PubMed ID: 18488412 [TBL] [Abstract][Full Text] [Related]
91. Enhancement of the solubility and efficacy of poorly water-soluble drugs by hydrophobically-modified polysaccharide derivatives. Henni-Silhadi W; Deyme M; Boissonnade MM; Appel M; Le Cerf D; Picton L; Rosilio V Pharm Res; 2007 Dec; 24(12):2317-26. PubMed ID: 17912487 [TBL] [Abstract][Full Text] [Related]
92. Effect of poly(N-vinyl-pyrrolidone)-block-poly(D,L-lactide) as coating agent on the opsonization, phagocytosis, and pharmacokinetics of biodegradable nanoparticles. Gaucher G; Asahina K; Wang J; Leroux JC Biomacromolecules; 2009 Feb; 10(2):408-16. PubMed ID: 19133718 [TBL] [Abstract][Full Text] [Related]
93. Influence of polysaccharide coating on the interactions of nanoparticles with biological systems. Lemarchand C; Gref R; Passirani C; Garcion E; Petri B; Müller R; Costantini D; Couvreur P Biomaterials; 2006 Jan; 27(1):108-18. PubMed ID: 16118015 [TBL] [Abstract][Full Text] [Related]